PALISADE CAPITAL MANAGEMENT, LP - INOVIO PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773HAB8. A total of 6 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$1,665,000
-22.7%
1,000,0000.0%0.04%
-32.8%
Q3 2020$2,155,000
-85.6%
1,000,000
-66.7%
0.06%
-86.6%
Q2 2020$15,012,000
+239.1%
3,000,0000.0%0.48%
+205.8%
Q1 2020$4,427,000–3,000,000–0.16%–
 Download
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AQR Arbitrage LLC 5,000,000$4,571,0000.12%
WOLVERINE ASSET MANAGEMENT LLC 6,415,000$6,081,0000.06%
D. E. Shaw & Co., Inc. 5,000,000$5,726,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders